About Samara Regional Clinical Cardiological Dispensary
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Samara Regional Clinical Cardiological Dispensary
During the past decade, Samara Regional Clinical Cardiological Dispensary conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on
average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
2007-05-01
2015-03-01
Completed
520
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
2009-04-29
2012-02-07
Completed
59
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
2006-06-26
2014-09-22
Completed
417
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Samara Regional Clinical Cardiological Dispensary" #1 sponsor was "Actelion" with 5 trials, followed by "Boehringer Ingelheim" with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Samara Regional Clinical Cardiological Dispensary"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Samara Regional Clinical Cardiological Dispensary
According to Clinical.Site data, the most researched conditions in "Samara Regional Clinical Cardiological Dispensary" are
"Cardiovascular Disease" (2 trials), "Hypertension, Pulmonary" (2 trials), "Juvenile Idiopathic Arthritis" (2 trials), "Pulmonary Arterial Hypertension" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Samara Regional Clinical Cardiological Dispensary" in a lesser frequency.
Clinical Trials Intervention Types at Samara Regional Clinical Cardiological Dispensary
Most popular intervention types in "Samara Regional Clinical Cardiological Dispensary" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Macitentan 10 mg" (2 trials), "Selexipag" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Samara Regional Clinical Cardiological Dispensary
The vast majority of trials in "Samara Regional Clinical Cardiological Dispensary" are
12 trials for "All" genders.
Clinical Trials Status at Samara Regional Clinical Cardiological Dispensary
Currently, there are NaN active trials in "Samara Regional Clinical Cardiological Dispensary".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Samara Regional Clinical Cardiological Dispensary,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Samara Regional Clinical Cardiological Dispensary, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".